Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild‐type and MAPT transgenic mice
暂无分享,去创建一个
W. Oertel | V. Guérineau | G. Höglinger | G. Respondek | Hong Xu | P. Champy | I. Schmitz-Afonso | M. Höllerhage | T. Rösler | E. S. Yamada | E. Bony | Jessica Le Ven | R. Rottscholl | Marlen Haegele | B. Jainsch
[1] S. Shim,et al. Immunomodulatory Efficacy of Standardized Annona muricata (Graviola) Leaf Extract via Activation of Mitogen-Activated Protein Kinase Pathways in RAW 264.7 Macrophages , 2016, Evidence-based complementary and alternative medicine : eCAM.
[2] S. Bandyopadhyay,et al. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators , 2016, Molecular Neurobiology.
[3] D. Touboul,et al. Method development for quantification of the environmental neurotoxin annonacin in Rat plasma by UPLC-MS/MS and application to a pharmacokinetic study. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[4] F. Ghorbani,et al. Homozygous MAPT R406W mutation causing FTDP phenotype: A unique instance of a unique mutation. , 2015, Gene.
[5] I. Ferrer,et al. High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents. , 2015, Biochimica et biophysica acta.
[6] Lynn A. Hyde,et al. Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology , 2015, Molecular Neurodegeneration.
[7] Francisco Melo,et al. Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo. , 2015, The Biochemical journal.
[8] C. Dickey,et al. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy , 2015, Acta neuropathologica communications.
[9] W. Oertel,et al. Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice , 2014, PloS one.
[10] D. Touboul,et al. Quantification of annonacin in Rat plasma: Application to pharmacokinetic study , 2014 .
[11] W. Oertel,et al. Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice , 2014, Experimental Neurology.
[12] T. Révész,et al. The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons , 2013, Acta Neuropathologica.
[13] Michel Goedert,et al. Tau pathology and neurodegeneration , 2013, The Lancet Neurology.
[14] D. Touboul,et al. Comprehensive characterization of Annonaceous acetogenins within a complex extract by HPLC-ESI-LTQ-Orbitrap® using post-column lithium infusion. , 2012, Journal of mass spectrometry : JMS.
[15] D. Touboul,et al. Annonaceous acetogenins within extracts: dereplication by HPLC-ESI-LTQ-Orbitrap® using post-column lithium infusion , 2012 .
[16] M. Singh,et al. A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration , 2012, Current neuropharmacology.
[17] S. Ohta,et al. Annonamine, a new aporphine alkaloid from the leaves of Annona muricata. , 2012, Chemical & pharmaceutical bulletin.
[18] C. Zhong,et al. Exposure to Pyrithiamine Increases β-Amyloid Accumulation, Tau Hyperphosphorylation, and Glycogen Synthase Kinase-3 Activity in the Brain , 2011, Neurotoxicity Research.
[19] G. Drewes,et al. The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2–dependent manner , 2011, The Journal of cell biology.
[20] K. Ashe,et al. Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.
[21] V. Guérineau,et al. MALDI-TOF MS Profiling of Annonaceous Acetogenins in Annona muricata Products for Human Consumption , 2009, Molecules.
[22] M. Ruberg,et al. Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies , 2009, Experimental Neurology.
[23] G. Waldemar,et al. Genetic testing in familial AD and FTD: Mutation and phenotype spectrum in a Danish cohort , 2009, Clinical genetics.
[24] J. Kordower,et al. Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease , 2009, Neurobiology of Disease.
[25] Baochang Cai,et al. Supercritical fluid CO2 extraction and simultaneous determination of eight annonaceous acetogenins in Annona genus plant seeds by HPLC-DAD method. , 2009, Journal of pharmaceutical and biomedical analysis.
[26] A. Miyashita,et al. Mutational Analysis in Early-Onset Familial Dementia in the Japanese Population , 2008, Dementia and Geriatric Cognitive Disorders.
[27] J. Stokholm,et al. Alzheimer disease‐like clinical phenotype in a family with FTDP‐17 caused by a MAPT R406W mutation , 2008, European journal of neurology.
[28] C. Mactutus,et al. Differential long‐term neurotoxicity of HIV‐1 proteins in the rat hippocampal formation: A design‐based stereological study , 2008, Hippocampus.
[29] S. Nelson,et al. Layer V neurons in mouse cortex projecting to different targets have distinct physiological properties. , 2007, Journal of neurophysiology.
[30] E. Hirsch,et al. Annonacin, a Natural Mitochondrial Complex I Inhibitor, Causes Tau Pathology in Cultured Neurons , 2007, The Journal of Neuroscience.
[31] B. Dubois,et al. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? , 2007, Brain : a journal of neurology.
[32] Bin Zhang,et al. Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.
[33] Weidong Zhang,et al. Characterization of isoquinoline alkaloids, diterpenoids and steroids in the Chinese herb Jin-Guo-Lan (Tinospora sagittata and Tinospora capillipes) by high-performance liquid chromatography/electrospray ionization with multistage mass spectrometry. , 2006, Rapid communications in mass spectrometry : RCM.
[34] D. Timm,et al. Pyrithiamine as a Substrate for Thiamine Pyrophosphokinase* , 2006, Journal of Biological Chemistry.
[35] M. Ruberg,et al. Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe , 2005, Movement disorders : official journal of the Movement Disorder Society.
[36] Jean Féger,et al. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy , 2005, Journal of neurochemistry.
[37] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[38] R. Ravid,et al. Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.
[39] G. Roué,et al. Annonaceous Acetogenins: The Hydroxyl Groups and THF Rings Are Crucial Structural Elements for Targeting the Mitochondria, Demonstration with the Synthesis of Fluorescent Squamocin Analogues , 2005, Chembiochem : a European journal of chemical biology.
[40] M. Zenk,et al. Analysis of Benzylisoquinoline-Type Alkaloids by Electrospray Tandem Mass Spectrometry and Atmospheric Pressure Photoionization , 2005, European journal of mass spectrometry.
[41] A. Bermejo,et al. Acetogenins from Annonaceae: recent progress in isolation, synthesis and mechanisms of action. , 2005, Natural product reports.
[42] Koji Abe,et al. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. , 2005, The American journal of pathology.
[43] H. Hara,et al. Detection and determination of reticuline and N-methylcoculaurine in the Annonaceae family using liquid chromatography-tandem mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[44] L. Lannfelt,et al. The Tau R406W Mutation Causes Progressive Presenile Dementia with Bitemporal Atrophy , 2004, Dementia and Geriatric Cognitive Disorders.
[45] E. Larsson,et al. Familial Presenile Dementia with Bitemporal Atrophy , 2004, Dementia and Geriatric Cognitive Disorders.
[46] Bin Zhang,et al. Retarded Axonal Transport of R406W Mutant Tau in Transgenic Mice with a Neurodegenerative Tauopathy , 2004, The Journal of Neuroscience.
[47] Jean-Louis Habib Jiwan,et al. Key fragmentation patterns of aporphine alkaloids by electrospray ionization with multistage mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.
[48] Jean Féger,et al. Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe , 2003, Journal of neurochemistry.
[49] A. Goate,et al. Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe , 2003, Human mutation.
[50] P Champy,et al. The mitochondrial complex i inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism , 2003, Neuroscience.
[51] J. Paul Robinson,et al. Mitochondrial Complex I Inhibitor Rotenone Induces Apoptosis through Enhancing Mitochondrial Reactive Oxygen Species Production* , 2003, The Journal of Biological Chemistry.
[52] T. Hashikawa,et al. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] T. Nagatsu. Amine-related neurotoxins in Parkinson's disease: past, present, and future. , 2002, Neurotoxicology and teratology.
[54] Charles Duyckaerts,et al. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. , 2002, Brain : a journal of neurology.
[55] Joshua M. Shulman,et al. Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles , 2001, Science.
[56] R. Ravid,et al. Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation. , 2001, The American journal of pathology.
[57] M. Goedert,et al. Reduced Binding of Protein Phosphatase 2A to Tau Protein with Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Mutations , 2000, Journal of neurochemistry.
[58] Patrick R Hof,et al. Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach , 2000, Journal of Chemical Neuroanatomy.
[59] J. Ávila,et al. The FTDP‐17‐Linked Mutation R406W Abolishes the Interaction of Phosphorylated Tau with Microtubules , 2000, Journal of neurochemistry.
[60] W. Kamphorst,et al. Phenotypic variation in hereditary frontotemporal dementia with tau mutations , 1999, Annals of neurology.
[61] Alexis Elbaz,et al. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study , 1999, The Lancet.
[62] G. Schellenberg,et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L) , 1999, Brain : a journal of neurology.
[63] C. Duijn,et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.
[64] M. Goedert,et al. Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.
[65] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[66] M. L. Schmidt,et al. Autosomal dominant dementia with widespread neurofibrillary tangles , 1997, Annals of neurology.
[67] T. Nagatsu. Isoquinoline neurotoxins in the brain and Parkinson's disease , 1997, Neuroscience Research.
[68] Philip R. Cohen,et al. Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases , 1997, FEBS letters.
[69] N L Foster,et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference , 1997, Annals of neurology.
[70] G. Vauquelin,et al. Screening of medicinal plants from Suriname for 5-HT(1A) ligands: Bioactive isoquinoline alkaloids from the fruit of Annona muricata. , 1997, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[71] N. Oberlies,et al. The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells. , 1997, Cancer letters.
[72] P. Forgacs,et al. [Alkaloids of Annonaceae. XXIX. Alkaloids of Annona muricata]. , 1981, Planta medica.
[73] R. Swerdlow,et al. Mitochondria, Cybrids, Aging, and Alzheimer's Disease. , 2017, Progress in molecular biology and translational science.
[74] N. Bhat,et al. Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet. , 2013, Journal of Alzheimer's disease : JAD.
[75] S. C. Smith,et al. Annonacin in Asimina triloba fruit: implication for neurotoxicity. , 2012, Neurotoxicology.
[76] C. Geula,et al. Selective tau tyrosine nitration in non-AD tauopathies , 2011, Acta Neuropathologica.
[77] Merle Ruberg,et al. Toxicity of Annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe , 2002, Movement disorders : official journal of the Movement Disorder Society.
[78] P. K. Bhaumik,et al. The phytochemistry of the annonaceae , 1980 .
[79] Glycogen Synthase Kinase 3 (cid:1) Phosphorylates Tau at Both Primed and Unprimed Sites , 2022 .